Cargando…
Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting
Repeated measures studies are frequently performed in patient-derived xenograft (PDX) models to evaluate drug activity or compare effectiveness of cancer treatment regimens. Linear mixed effects regression models were used to perform statistical modeling of tumor growth data. Biologically plausible...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044116/ https://www.ncbi.nlm.nih.gov/pubmed/33850213 http://dx.doi.org/10.1038/s41598-021-87470-x |
_version_ | 1783678417838800896 |
---|---|
author | Oberg, Ann L. Heinzen, Ethan P. Hou, Xiaonan Al Hilli, Mariam M. Hurley, Rachel M. Wahner Hendrickson, Andrea E. Goergen, Krista M. Larson, Melissa C. Becker, Marc A. Eckel-Passow, Jeanette E. Maurer, Matthew J. Kaufmann, Scott H. Haluska, Paul Weroha, S. John |
author_facet | Oberg, Ann L. Heinzen, Ethan P. Hou, Xiaonan Al Hilli, Mariam M. Hurley, Rachel M. Wahner Hendrickson, Andrea E. Goergen, Krista M. Larson, Melissa C. Becker, Marc A. Eckel-Passow, Jeanette E. Maurer, Matthew J. Kaufmann, Scott H. Haluska, Paul Weroha, S. John |
author_sort | Oberg, Ann L. |
collection | PubMed |
description | Repeated measures studies are frequently performed in patient-derived xenograft (PDX) models to evaluate drug activity or compare effectiveness of cancer treatment regimens. Linear mixed effects regression models were used to perform statistical modeling of tumor growth data. Biologically plausible structures for the covariation between repeated tumor burden measurements are explained. Graphical, tabular, and information criteria tools useful for choosing the mean model functional form and covariation structure are demonstrated in a Case Study of five PDX models comparing cancer treatments. Power calculations were performed via simulation. Linear mixed effects regression models applied to the natural log scale were shown to describe the observed data well. A straight growth function fit well for two PDX models. Three PDX models required quadratic or cubic polynomial (time squared or cubed) terms to describe delayed tumor regression or initial tumor growth followed by regression. Spatial(power), spatial(power) + RE, and RE covariance structures were found to be reasonable. Statistical power is shown as a function of sample size for different levels of variation. Linear mixed effects regression models provide a unified and flexible framework for analysis of PDX repeated measures data, use all available data, and allow estimation of tumor doubling time. |
format | Online Article Text |
id | pubmed-8044116 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-80441162021-04-14 Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting Oberg, Ann L. Heinzen, Ethan P. Hou, Xiaonan Al Hilli, Mariam M. Hurley, Rachel M. Wahner Hendrickson, Andrea E. Goergen, Krista M. Larson, Melissa C. Becker, Marc A. Eckel-Passow, Jeanette E. Maurer, Matthew J. Kaufmann, Scott H. Haluska, Paul Weroha, S. John Sci Rep Article Repeated measures studies are frequently performed in patient-derived xenograft (PDX) models to evaluate drug activity or compare effectiveness of cancer treatment regimens. Linear mixed effects regression models were used to perform statistical modeling of tumor growth data. Biologically plausible structures for the covariation between repeated tumor burden measurements are explained. Graphical, tabular, and information criteria tools useful for choosing the mean model functional form and covariation structure are demonstrated in a Case Study of five PDX models comparing cancer treatments. Power calculations were performed via simulation. Linear mixed effects regression models applied to the natural log scale were shown to describe the observed data well. A straight growth function fit well for two PDX models. Three PDX models required quadratic or cubic polynomial (time squared or cubed) terms to describe delayed tumor regression or initial tumor growth followed by regression. Spatial(power), spatial(power) + RE, and RE covariance structures were found to be reasonable. Statistical power is shown as a function of sample size for different levels of variation. Linear mixed effects regression models provide a unified and flexible framework for analysis of PDX repeated measures data, use all available data, and allow estimation of tumor doubling time. Nature Publishing Group UK 2021-04-13 /pmc/articles/PMC8044116/ /pubmed/33850213 http://dx.doi.org/10.1038/s41598-021-87470-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Oberg, Ann L. Heinzen, Ethan P. Hou, Xiaonan Al Hilli, Mariam M. Hurley, Rachel M. Wahner Hendrickson, Andrea E. Goergen, Krista M. Larson, Melissa C. Becker, Marc A. Eckel-Passow, Jeanette E. Maurer, Matthew J. Kaufmann, Scott H. Haluska, Paul Weroha, S. John Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting |
title | Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting |
title_full | Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting |
title_fullStr | Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting |
title_full_unstemmed | Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting |
title_short | Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting |
title_sort | statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (pdx) setting |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044116/ https://www.ncbi.nlm.nih.gov/pubmed/33850213 http://dx.doi.org/10.1038/s41598-021-87470-x |
work_keys_str_mv | AT obergannl statisticalanalysisofcomparativetumorgrowthrepeatedmeasuresexperimentsintheovariancancerpatientderivedxenograftpdxsetting AT heinzenethanp statisticalanalysisofcomparativetumorgrowthrepeatedmeasuresexperimentsintheovariancancerpatientderivedxenograftpdxsetting AT houxiaonan statisticalanalysisofcomparativetumorgrowthrepeatedmeasuresexperimentsintheovariancancerpatientderivedxenograftpdxsetting AT alhillimariamm statisticalanalysisofcomparativetumorgrowthrepeatedmeasuresexperimentsintheovariancancerpatientderivedxenograftpdxsetting AT hurleyrachelm statisticalanalysisofcomparativetumorgrowthrepeatedmeasuresexperimentsintheovariancancerpatientderivedxenograftpdxsetting AT wahnerhendricksonandreae statisticalanalysisofcomparativetumorgrowthrepeatedmeasuresexperimentsintheovariancancerpatientderivedxenograftpdxsetting AT goergenkristam statisticalanalysisofcomparativetumorgrowthrepeatedmeasuresexperimentsintheovariancancerpatientderivedxenograftpdxsetting AT larsonmelissac statisticalanalysisofcomparativetumorgrowthrepeatedmeasuresexperimentsintheovariancancerpatientderivedxenograftpdxsetting AT beckermarca statisticalanalysisofcomparativetumorgrowthrepeatedmeasuresexperimentsintheovariancancerpatientderivedxenograftpdxsetting AT eckelpassowjeanettee statisticalanalysisofcomparativetumorgrowthrepeatedmeasuresexperimentsintheovariancancerpatientderivedxenograftpdxsetting AT maurermatthewj statisticalanalysisofcomparativetumorgrowthrepeatedmeasuresexperimentsintheovariancancerpatientderivedxenograftpdxsetting AT kaufmannscotth statisticalanalysisofcomparativetumorgrowthrepeatedmeasuresexperimentsintheovariancancerpatientderivedxenograftpdxsetting AT haluskapaul statisticalanalysisofcomparativetumorgrowthrepeatedmeasuresexperimentsintheovariancancerpatientderivedxenograftpdxsetting AT werohasjohn statisticalanalysisofcomparativetumorgrowthrepeatedmeasuresexperimentsintheovariancancerpatientderivedxenograftpdxsetting |